Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06023225 · ClinicalTrials.gov registry record
Sex Hormones, Postoperative Pain and Opioid Use
A clinical trial of Opioid Use and Postoperative Pain, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT06023225 is a study of Opioid Use and Postoperative Pain that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 210 participants, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06023225, a study of Opioid Use and Postoperative Pain, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors
Conditions Studied
Interventions
- BEHAVIORAL Pain
- BEHAVIORAL Opioid use
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2029-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06023225
The ClinicalTrials.gov registry entry for NCT06023225 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,258-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Pain is the first listed.
NCT06023225 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT06023225 about?
NCT06023225 is a clinical study titled "Sex Hormones, Postoperative Pain and Opioid Use". Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors
What is the current status of trial NCT06023225?
This trial is currently recruiting. The enrollment target is 210 participants. The study started on 2023-09-01. Estimated completion is 2029-07-01.
What conditions does trial NCT06023225 study?
This clinical trial studies the following conditions: Opioid Use, Postoperative Pain.
What interventions are being tested in trial NCT06023225?
The interventions under investigation include: Pain (BEHAVIORAL), Opioid use (BEHAVIORAL).
Who is sponsoring clinical trial NCT06023225?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06023225 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
RECRUITING · Phase 3
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Opioid Use After Laparoscopic Salpingectomy
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.